Global N-Formyl Peptide Receptor 2 Market Growth (Status and Outlook) 2025-2031

The global N-Formyl Peptide Receptor 2 market size is predicted to grow from US$ 55.1 million in 2025 to US$ 142 million in 2031; it is expected to grow at a CAGR of 17.1% from 2025 to 2031.

N-formyl peptide receptor 2 (FPR2) is a G-protein coupled receptor (GPCR) located on the surface of many cell types of various animal species. The human receptor protein is encoded by the FPR2 gene and is activated to regulate cell function by binding any one of a wide variety of ligands including not only certain N-Formylmethionine-containing oligopeptides such as N-Formylmethionine-leucyl-phenylalanine (FMLP) but also the polyunsaturated fatty acid metabolite of arachidonic acid, lipoxin A4 (LXA4). Because of its interaction with lipoxin A4, FPR2 is also commonly named the ALX/FPR2 or just ALX receptor. FPR2 is mainly distributed in human immune cells, regulates a variety of important physiological functions, is widely involved in the occurrence and development of various inflammatory diseases, and is closely related to serious diseases such as Alzheimer's disease, AIDS and Crohn's disease. Unlike most GPCRs, FPR2 recognizes a variety of ligands with very different structures, including formyl peptides, non-formyl peptides, lipids, small molecules and proteins, and produces different functions such as anti-inflammatory and anti-inflammatory functions, which makes FPR2 one of the most complex GPCRs with the most complex mechanism of ligand recognition and functional transitions discovered so far. Due to the unknown mechanism of action of FPR2 and its ligand molecules, the development of drugs targeting this receptor has been slow, and no drug has been successfully marketed yet. Since FPR2 drugs are still in the development stage, in this report, we study FPR2 agonists and antagonists chemicals.

The core manufacturers in global N-Formyl Peptide Receptor 2 market are Bio-Techne, Alomone Labs, Merck, Abcam and MedChemExpress, etc, accounting for 45% market share. Bio-Techne is the world's largest N-Formyl Peptide Receptor 2 manufacturer, occupying approximately 20% of the market share. From the perspective of product type, Agonists accounted for a share of 84% in the global N-Formyl Peptide Receptor 2 market. In terms of application, Pharmaceutical Company holds the largest share, accounting for 72% share.

LPI (LP Information)' newest research report, the “N-Formyl Peptide Receptor 2 Industry Forecast” looks at past sales and reviews total world N-Formyl Peptide Receptor 2 sales in 2024, providing a comprehensive analysis by region and market sector of projected N-Formyl Peptide Receptor 2 sales for 2025 through 2031. With N-Formyl Peptide Receptor 2 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world N-Formyl Peptide Receptor 2 industry.

This Insight Report provides a comprehensive analysis of the global N-Formyl Peptide Receptor 2 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on N-Formyl Peptide Receptor 2 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global N-Formyl Peptide Receptor 2 market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for N-Formyl Peptide Receptor 2 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global N-Formyl Peptide Receptor 2.

This report presents a comprehensive overview, market shares, and growth opportunities of N-Formyl Peptide Receptor 2 market by product type, application, key players and key regions and countries.

Segmentation by Type:
Agonists
Antagonists

Segmentation by Application:
Pharmaceutical Company
Universities and Research Institutes
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bio-Techne
Abcam
Enzo Life Sciences
MedChemExpress
Anaspec
Merck
Discoverx
BioGems
GenScript Company
Alomone Labs

Please note: The report will take approximately 2 business days to prepare and deliver.